BioSante Pharmaceuticals Inc. (NASDAQ: BPAX)
Date:
Mon, 12/19/2011
December 19th, 2011 we were notifiying the bounce potential on NASDAQ: BPAX on our social media networks as shares seem oversold on news that results from two pivotal Phase III LibiGel (testosterone gel) did not meet the co-primary or secondary endpoints. Soon after we released on January 13th, 2011 our research article, "TooNiceStocks Initiates Coverage on BioSante Pharmaceuticals Inc. (NASDAQ: BPAX) Looming FDA Decision with Elevated Interest". Our members were notified BPAX was down but not done @ $.38 and the bounce or rally toward February 14th, 2012 PDFUFA date for Bio-T-Gel, a testosterone gel for male hypogonadism reaches up to $1.23 or up to 220%. Read full research report here.
